COPD and triple therapy: When we should and shouldn’t use it – Your questions answered

   Rated 5 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0.5 hours

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 hours

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 hours

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

  1. How do we go about dignosing COPD?
  2. Do GPs need to refer patients to a respiratory lab?
  3. How to assess patients and if there is an issue?
  4. Are questions that give GPs an idea of progression over time useful?
  5. Would you do bronchial challenge tests in COPD patients to further differentiate who should and shouldn’t get inhaled corticosteroids?
  6. Does vaping increase the risk for COPD?
  7. How do you manage patients with early airflow limitation and symptoms? But who don’t yet meet the criteria for COPD?
  8. Is the treatment of emphysema, the same as for chronic bronchitis?
  9. How can GPs suspect the patient actually has more of a chronic bronchitis issue then a COPD issue?
  10. Is there any role for imaging?
  11. With regard to thyroid function, what are you looking for?
  12. How can you define frequent exacerbations?
  13. What changes in management would you advise with the management of bronchiectasis in the setting of a patient with COPD?
  14. What are the adverse reactions to drugs – Seretide and a risk of pneumonia

Guest: A/Prof Natasha Smallwood, Respiratory Physician

Host: Dr David Lim, GP and Medical Educator

Total time: 41 mins

Last Updated: 10 Oct, 2023

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Emily Nash

Dr Emily Nash

Abnormal Liver Function Test

Prof Richard Harvey

Prof Richard Harvey

Recurrent Nasal Polyps Management – When to Refer

Prof Kelly-Anne Phillips

Prof Kelly-Anne Phillips

Breast Density and Cancer Risk – What Every GP Can Put into Practice Tomorrow

A/Prof Adrian Mar

A/Prof Adrian Mar

Vitiligo – Early Detection and Early Treatment

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Upcoming Healthed Webcast

Recurrent Nasal Polyps Management – When to Refer

Tuesday 31st March, 7pm - 9pm AEDT

Speaker

Prof Richard Harvey

Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon

Join Professor Richard Harvey for an overview of our current understanding of the pathophysiology of nasal polyps.